AAAAAA
Results:
1-24
|
Results: 24
Authors:
Westendorp, RGJ
van Dunne, GM
Kirkwood, TBL
Helmerhorst, FM
Huizinga, TWJ
Citation: Rgj. Westendorp et al., Optimizing human fertility and survival, NAT MED, 7(8), 2001, pp. 873-873
Authors:
Vandenbroucke, JP
van der Meer, FJM
Helmerhorst, FM
Rosendaal, FR
Citation: Jp. Vandenbroucke et al., Family history and risk of venous thromboembolism with oral contraception - Family history is important tool, BR MED J, 323(7315), 2001, pp. 752-752
Authors:
Rosendaal, FR
Helmerhorst, FM
Vandenbroucke, JP
Citation: Fr. Rosendaal et al., Oral contraceptives, hormone replacement therapy and thrombosis, THROMB HAEM, 86(1), 2001, pp. 112-123
Authors:
Bloemenkamp, KWM
de Groot, CJM
De Ronde, H
Duvekot, EJ
Helmerhorst, FM
Bertina, RM
Citation: Kwm. Bloemenkamp et al., The effect of factor V Leiden, oral contraceptive use: type of oral contraceptives and pregnancy on APC-r levels in women with or without a history of pre-eclampsia, EUR J OB GY, 95(2), 2001, pp. 225-225
Authors:
Oei, SG
Helmerhorst, FM
Keirse, MJN
Citation: Sg. Oei et al., Routine postcoital testing is unnecessary, HUM REPR, 16(5), 2001, pp. 1051-1052
Authors:
de Koning, J
Lambalk, CB
Helmerhorst, FM
Helder, MN
Citation: J. De Koning et al., Is GnRH self-priming an obligatory feature of the reproductive cycle?, HUM REPR, 16(2), 2001, pp. 209-214
Authors:
Vandenbroucke, JP
Rosing, J
Bloemenkamp, KWM
Middeldorp, S
Helmerhorst, FM
Bouma, BN
Rosendaal, FR
Citation: Jp. Vandenbroucke et al., Oral contraceptives and the risk of venous thrombosis., N ENG J MED, 344(20), 2001, pp. 1527-1535
Authors:
Koolwijk, P
Kapiteijn, K
Molenaar, B
van Spronsen, E
van der Vecht, B
Helmerhorst, FM
van Hinsbergh, VWM
Citation: P. Koolwijk et al., Enhanced angiogenic capacity and urokinase-type plasminogen activator expression by endothelial cells isolated from human endometrium, J CLIN END, 86(7), 2001, pp. 3359-3367
Authors:
Ludicke, F
Johannisson, E
Helmerhorst, FM
Campana, A
Foidart, JM
Heithecker, R
Citation: F. Ludicke et al., Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 mu g of ethinyl estradiol on the human endometrium, FERT STERIL, 76(1), 2001, pp. 102-107
Authors:
Bloemenkamp, KWM
Helmerhorst, FM
Rosendaal, FR
Vandenbroucke, JP
Citation: Kwm. Bloemenkamp et al., Lack of objectivity in the debate concerning third-generation oral contraceptives and venous thrombosis - In reply, ARCH IN MED, 161(3), 2001, pp. 484-485
Authors:
Vandenbroucke, JP
Helmerhorst, FM
Rosendaal, FR
Citation: Jp. Vandenbroucke et al., Competing interests and controversy about third generation oral contraceptives - BMJ readers should know whose words they read, BR MED J, 320(7231), 2000, pp. 381-382
Authors:
Vandenbroucke, JP
Bloemenkamp, KWM
Rosendaal, FR
Helmerhorst, FM
Citation: Jp. Vandenbroucke et al., Incidence of venous thromboembolism in users of combined oral contraceptives - Risk is particularly high with first use of oral contraceptives, BR MED J, 320(7226), 2000, pp. 57-57
Authors:
Oelkers, W
Helmerhorst, FM
Wuttke, W
Heithecker, R
Citation: W. Oelkers et al., Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers, GYNECOL END, 14(3), 2000, pp. 204-213
Authors:
Koudstaal, J
Bruinse, HW
Helmerhorst, FM
Vermeiden, JPW
Willemsen, WNP
Visser, GHA
Citation: J. Koudstaal et al., Obstetric outcome of twin pregnancies after in-vitro fertilization: a matched control study in four Dutch University hospitals, HUM REPR, 15(4), 2000, pp. 935-940
Authors:
Helmerhorst, FM
Erwich, JJ
Citation: Fm. Helmerhorst et Jj. Erwich, Comment on the use of the MAR test using latex beads, HUM REPR, 15(2), 2000, pp. 233-233
Authors:
Bloemenkamp, KWM
Rosendaal, FR
Helmerhorst, FM
Vandenbroucke, JP
Citation: Kwm. Bloemenkamp et al., Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects, ARCH IN MED, 160(1), 2000, pp. 49-52
Authors:
Oei, SG
Helmerhorst, FM
Keirse, MJNC
Citation: Sg. Oei et al., Postcoital testing - Postcoital test should be performed as routine infertility test - Reply, BR MED J, 318(7189), 1999, pp. 1008-1009
Authors:
Bloemenkamp, KWM
Helmerhorst, FM
Rosendaal, FR
Vandenbroucke, JP
Citation: Kwm. Bloemenkamp et al., Venous thrombosis, oral contraceptives and high factor VIII levels, THROMB HAEM, 82(3), 1999, pp. 1024-1027
Authors:
Helmerhorst, FM
Finken, MJJ
Erwich, JJ
Citation: Fm. Helmerhorst et al., Antisperm antibodies - Detection assays for antisperm antibodies: what do they test?, HUM REPR, 14(7), 1999, pp. 1669-1671
Authors:
Rad, NAK
Helmerhorst, FM
Citation: Nak. Rad et Fm. Helmerhorst, OHSS and cerebrovascular thrombosis, HUM REPR, 14(4), 1999, pp. 1138-1138
Authors:
Van der Westerlaken, LAJ
Helmerhorst, FM
Hermans, J
Naaktgeboren, N
Citation: Laj. Van Der Westerlaken et al., Intracytoplasmic sperm injection: position of the polar body affects pregnancy rate, HUM REPR, 14(10), 1999, pp. 2565-2569
Authors:
Bloemenkamp, KW
Rosendaal, FR
Helmerhorst, FM
Vandenbroucke, JP
Citation: Kw. Bloemenkamp et al., Venous thromboembolism and oral contraceptives, LANCET, 354(9188), 1999, pp. 1469-1469
Authors:
Bloemenkamp, KWM
Rosendaal, FP
Buller, HR
Helmerhorst, FM
Colly, LP
Vandenbroucke, JP
Citation: Kwm. Bloemenkamp et al., Risk of venous thrombosis with use of current low-dose oral contraceptivesis not explained by diagnostic suspicion and referral bias, ARCH IN MED, 159(1), 1999, pp. 65-70
Authors:
De Groot, CJM
Bloemenkamp, KWM
Duvekot, EJ
Helmerhorst, FM
Bertina, RM
Van der Meer, F
De Ronde, H
Oei, SG
Kanhai, HHH
Rosendaal, FR
Citation: Cjm. De Groot et al., Preeclampsia and genetic risk factors for thrombosis: A case-control study, AM J OBST G, 181(4), 1999, pp. 975-980
Risultati:
1-24
|